1 Dyson NJ.RB1:a prototype tumor suppressor and an enigma[J].Genes Dev,2016,30(13):1492-1502. 2 Riley DJ,Liu CY,Lee WH.Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression[J].Mol Cell Biol,1997,17(12):7342-7352. 3 Wong S,Weber JD.Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1[J].Biochem J,2007,407(3):451-460. 4 Lejon S,Thong SY,Murthy A,et al.Insights into association of the NuRD complex with FOG-1 from the crystal structure of an RbAp48.FOG-1 complex[J].J Biol Chem,2011,286(2):1196-1203. 5 Qian YW,Wang YC,Hollingsworth RJ,et al.A retinoblastoma-binding protein related to a negative regulator of Ras in yeast[J].Nature,1993,364(6438):648-652. 6 Tsujii A,Miyamoto Y,Moriyama T,et al.Retinoblastoma-binding protein 4-regulated classical nuclear transport is involved in cellular senescence[J].J Biol Chem,2015,290(49):29375-29388. 7 Zhang W,Tyl M,Ward R,et al.Structural plasticity of histones H3-H4 facilitates their allosteric exchange between RbAp48 and ASF1[J].Nat Struct Mol Biol,2013,20(1):29-35. 8 Wu S,Wang L,Ren X,et al.Involvement of retinoblastoma-associated protein 48 during photodynamic therapy of cervical cancer cells[J].Mol Med Rep,2017,15(3):1393-1400. 9 Kruger AV,Jelier R,Dzyubachyk O,et al.Comprehensive single cell-resolution analysis of the role of chromatin regulators in early C.elegans embryogenesis[J].Dev Biol,2015,398(2):153-162. 10 Satrimafitrah P,Barman HK,Ahmad A,et al.RbAp48 is essential for viability of vertebrate cells and plays a role in chromosome stability[J].Chromosome Res,2016,24(2):161-173. 11 Pacifico F,Paolillo M,Chiappetta G,et al.RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer[J].J Clin Endocrinol Metab,2007,92(4):1458-1466. 12 Yang XJ,Seto E.The Rpd3/Hda1 family of lysine deacetylases:from bacteria and yeast to mice and men[J].Nat Rev Mol Cell Biol,2008,9(3):206-218. 13 Haberland M,Montgomery RL,Olson EN.The many roles of histone deacetylases in development and physiology:implications for disease and therapy[J].Nat Rev Genet,2009,10(1):32-42. 14 刘春艳,孙海晶,陆军,等.组蛋白乙酰化与癌症[J].生物化学与生物物理进展,2003,30(1):19-23. 15 Richards EJ,Elgin SC.Epigenetic codes for heterochromatin formation and silencing:rounding up the usual suspects[J].Cell,2002,108(4):489-500. 16 Takahashi Y,Rayman JB,Dynlacht BD.Analysis of promoter binding by the E2F and pRB families in vivo:distinct E2F proteins mediate activation and repression[J].Genes Dev,2000,14(7):804-816. 17 Zhan L,Zhang Y,Wang W,et al.E2F1:a promising regulator in ovarian carcinoma[J].Tumour Biol,2016,37(3):2823-2831. 18 DeGregori J,Johnson DG.Distinct and overlapping roles for E2F family members in transcription,proliferation and apoptosis[J].Curr Mol Med,2006,6(7):739-748. 19 Sharma N,Timmers C,Trikha P,et al.Control of the p53-p21CIP1 Axis by E2f1,E2f2,and E2f3 is essential for G1/S progression and cellular transformation[J].J Biol Chem,2006,281(47):36124-36131. 20 Shao Y,Qu Y,Dang S,et al.MiR-145 inhibits oral squamous cell carcinoma(OSCC)cell growth by targeting c-Myc and Cdk6[J].Cancer Cell Int,2013,13(1):51. 21 Dyson N.The regulation of E2F by pRB-family proteins[J].Genes Dev,1998,12(15):2245-2262. 22 Brehm A,Miska EA,McCance DJ,et al.Retinoblastoma protein recruits histone deacetylase to repress transcription[J].Nature,1998,391(6667):597-601. 23 Nicolas E,Morales V,Magnaghi-Jaulin L,et al.RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein[J].J Biol Chem,2000,275(13):9797-9804. 24 Pacifico F,Paolillo M,Chiappetta G,et al.RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer[J].J Clin Endocrinol Metab,2007,92(4):1458-1466. 25 钟晶晶.下调RbAp48表达对人宫颈癌细胞增殖转移的抑制作用及其机制的研究[D].广州:南方医科大学,2016. 26 Song H,Xia SL,Liao C,et al.Genes encoding Pir51,Beclin 1,RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma[J].World J Gastroenterol,2004,10(4):509-513. 27 Fukuoka J,Fujii T,Shih JH,et al.Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer[J].Clin Cancer Res,2004,10(13):4314-4324. 28 张永晶.RbAp48蛋白在宫颈鳞癌中的表达及临床意义[D].长沙:中南大学,2009. 29 曹阓,范松龙,张智弘.胃癌中RBBP4和BCL-2的表达及意义[J].临床与实验病理学杂志,2017(10):1070-1073. 30 Bai X,Wang D,Ji H,et al.RbAp48 is critical for the proliferation of hypopharyngeal carcinoma[J].ORL J Otorhinolaryngol Relat Spec,2015,77(5):310-319. 31 贾淑青,方锐华,莫金雪.干扰HDAC1通过调控STAT3信号通路影响皮肤鳞癌细胞凋亡[J].中国病理生理杂志,2018,34(3):452-457. 32 Senese S,Zaragoza K,Minardi S,et al.Role for histone deacetylase 1 in human tumor cell proliferation[J].Mol Cell Biol,2007,27(13):4784-4795. 33 Nakagawa M,Oda Y,Eguchi T,et al.Expression profile of class I histone deacetylases in human cancer tissues[J].Oncol Rep,2007,18(4):769-774. 34 付小玲,薛秀珍.HDAC1、DNMT1、RECK在宫颈癌组织中的表达及其相关性[J].山东医药,2013,53(12):41-43. 35 任媛媛,王雅杰.HDAC1和DNMT1蛋白在乳腺癌中的表达及临床意义[J].临床肿瘤学杂志,2010,15(2):101-105. 36 伍宏彪,吴巨钢,张鹏,等.胃癌进展中转录因子E2F1的表达变化及其意义[J].中国普外基础与临床杂志,2010,17(6):573-580. 37 Chen HZ,Tsai SY,Leone G.Emerging roles of E2Fs in cancer:an exit from cell cycle control[J].Nat Rev Cancer,2009,9(11):785-797. 38 Georgiadi EC,Dimtsas GS,Vassilakopoulos TP,et al.Functional p53 can modulate the relationship between E2F-1 expression and tumor kinetics in Hodgkin lymphoma[J].Leuk Lymphoma,2015,56(3):748-754. 39 Li Z,Guo Y,Jiang H,et al.Differential regulation of MMPs by E2F1,Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype[J].BMC Cancer,2014,14:276. 40 Gao Z,Shi R,Yuan K,et al.Expression and prognostic value of E2F activators in NSCLC and subtypes:a research based on bioinformatics analysis[J].Tumour Biol,2016,37(11):14979-14987. |